Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Everaert

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Journal of Neuro-Oncology|September 28, 2010
Phase II study of sunitinib malate in patients with recurrent high-grade gliomaB Neyns, J Sadones, C Chaskis, et al.
Lung Cancer (Amsterdam, Netherlands)|February 14, 2012
Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neuJ De Grève, E Teugels, C Geers, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 21, 2007
In vivo visualization of 111In labeled CD133+ peripheral blood stem cells after intracoronary administration in patients with chronic ischemic heart diseaseV Caveliers, G De Keulenaer, H Everaert, et al.
Journal of Neuro-Oncology|March 4, 2016
Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastomaJ Duerinck, S Du Four, F Vandervorst, et al.
ESMO Open|April 10, 2026
Efficacy and safety of regorafenib in patients with advanced pretreated melanoma: results of the RegoMel phase II clinical trialI Dirven, C Bertels, Y Moreels, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Journal of Neuro-Oncology|September 28, 2010
Phase II study of sunitinib malate in patients with recurrent high-grade gliomaB Neyns, J Sadones, C Chaskis, et al.
Lung Cancer (Amsterdam, Netherlands)|February 14, 2012
Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neuJ De Grève, E Teugels, C Geers, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 21, 2007
In vivo visualization of 111In labeled CD133+ peripheral blood stem cells after intracoronary administration in patients with chronic ischemic heart diseaseV Caveliers, G De Keulenaer, H Everaert, et al.
Journal of Neuro-Oncology|March 4, 2016
Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastomaJ Duerinck, S Du Four, F Vandervorst, et al.
ESMO Open|April 10, 2026
Efficacy and safety of regorafenib in patients with advanced pretreated melanoma: results of the RegoMel phase II clinical trialI Dirven, C Bertels, Y Moreels, et al.
Pageof 5